Tags

Type your tag names separated by a space and hit enter

Comparison of faecal microbiota in Blastocystis-positive and Blastocystis-negative irritable bowel syndrome patients.
Microbiome 2016; 4(1):47M

Abstract

BACKGROUND

We investigated whether the carriage of Blastocystis in IBS patients was associated with differences in the faecal microbiota. Forty patients with diarrhoea-predominant IBS (26 Blastocystis-positive and 14 Blastocystis-negative) and 57 healthy controls (HC) (42 Blastocystis-positive and 15 Blastocystis-negative) submitted faecal samples for metataxonomic analysis of the 16S ribosomal RNA gene. Differences in the relative abundance of bacteria in these IBS and HC groups were evaluated from phylum to genus level.

RESULTS

Significant changes were observed in two dominant phyla in IBS patients, regardless of Blastocystis infection status, namely a rise in Firmicutes and a statistically significant reduction in relative abundance of Bacteroidetes (with a threefold increase in the Firmicutes to Bacteoridetes ratio). Significant differences at genus level in IBS subjects compared to HC were also observed for many bacterial species. However, further clinical subgroup analysis of Blastocystis-positive and Blastocystis-negative subjects, regardless of symptoms, showed no significant differences at the phylum or genus level in IBS-P compared to IBS-N.

CONCLUSIONS

Significant differences in the faecal microbiota between diarrhoea-predominant IBS patients and healthy controls were confirmed, but the carriage of Blastocystis did not significantly alter the faecal microbiota. If Blastocystis-positive patients represent a separate clinical subtype of IBS, this group is not identified by changes in the microbiota.

Authors+Show Affiliations

School of Veterinary Science, The University of Queensland, Gatton Campus, Brisbane, Queensland, 4343, Australia. robyn@tgclinic.com.au. Toowoomba Gastroenterology Clinic, Suite 105 Medici Medical Centre, 15 Scott St, Toowoomba, QLD, 4350, Australia. robyn@tgclinic.com.au.Faculty of Veterinary and Agricultural Sciences, University of Melbourne, Parkville, Melbourne, Victoria, 3052, Australia.School of Pathology and Laboratory Medicine, University of Western Australia, Crawley, Western Australia, 6009, Australia.Rural Clinical School, School of Medicine, The University of Queensland, Toowoomba, 4350, Australia.Australian Infectious Diseases Research Centre, The University of Queensland, St. Lucia, Queensland, 4072, Australia.

Pub Type(s)

Comparative Study
Journal Article
Research Support, Non-U.S. Gov't

Language

eng

PubMed ID

27580855

Citation

Nagel, Robyn, et al. "Comparison of Faecal Microbiota in Blastocystis-positive and Blastocystis-negative Irritable Bowel Syndrome Patients." Microbiome, vol. 4, no. 1, 2016, p. 47.
Nagel R, Traub RJ, Allcock RJ, et al. Comparison of faecal microbiota in Blastocystis-positive and Blastocystis-negative irritable bowel syndrome patients. Microbiome. 2016;4(1):47.
Nagel, R., Traub, R. J., Allcock, R. J., Kwan, M. M., & Bielefeldt-Ohmann, H. (2016). Comparison of faecal microbiota in Blastocystis-positive and Blastocystis-negative irritable bowel syndrome patients. Microbiome, 4(1), p. 47. doi:10.1186/s40168-016-0191-0.
Nagel R, et al. Comparison of Faecal Microbiota in Blastocystis-positive and Blastocystis-negative Irritable Bowel Syndrome Patients. Microbiome. 2016 08 31;4(1):47. PubMed PMID: 27580855.
* Article titles in AMA citation format should be in sentence-case
TY - JOUR T1 - Comparison of faecal microbiota in Blastocystis-positive and Blastocystis-negative irritable bowel syndrome patients. AU - Nagel,Robyn, AU - Traub,Rebecca J, AU - Allcock,Richard J N, AU - Kwan,Marcella M S, AU - Bielefeldt-Ohmann,Helle, Y1 - 2016/08/31/ PY - 2015/10/04/received PY - 2016/08/09/accepted PY - 2016/9/2/entrez PY - 2016/9/2/pubmed PY - 2017/7/7/medline KW - Blastocystis KW - Faecal microbiota KW - Irritable bowel syndrome SP - 47 EP - 47 JF - Microbiome JO - Microbiome VL - 4 IS - 1 N2 - BACKGROUND: We investigated whether the carriage of Blastocystis in IBS patients was associated with differences in the faecal microbiota. Forty patients with diarrhoea-predominant IBS (26 Blastocystis-positive and 14 Blastocystis-negative) and 57 healthy controls (HC) (42 Blastocystis-positive and 15 Blastocystis-negative) submitted faecal samples for metataxonomic analysis of the 16S ribosomal RNA gene. Differences in the relative abundance of bacteria in these IBS and HC groups were evaluated from phylum to genus level. RESULTS: Significant changes were observed in two dominant phyla in IBS patients, regardless of Blastocystis infection status, namely a rise in Firmicutes and a statistically significant reduction in relative abundance of Bacteroidetes (with a threefold increase in the Firmicutes to Bacteoridetes ratio). Significant differences at genus level in IBS subjects compared to HC were also observed for many bacterial species. However, further clinical subgroup analysis of Blastocystis-positive and Blastocystis-negative subjects, regardless of symptoms, showed no significant differences at the phylum or genus level in IBS-P compared to IBS-N. CONCLUSIONS: Significant differences in the faecal microbiota between diarrhoea-predominant IBS patients and healthy controls were confirmed, but the carriage of Blastocystis did not significantly alter the faecal microbiota. If Blastocystis-positive patients represent a separate clinical subtype of IBS, this group is not identified by changes in the microbiota. SN - 2049-2618 UR - https://www.unboundmedicine.com/medline/citation/27580855/Comparison_of_faecal_microbiota_in_Blastocystis_positive_and_Blastocystis_negative_irritable_bowel_syndrome_patients_ L2 - https://microbiomejournal.biomedcentral.com/articles/10.1186/s40168-016-0191-0 DB - PRIME DP - Unbound Medicine ER -